Clinical Ovarian Cancer - Volume 3 - Issue 1

The 41st Annual Meeting on Women's Cancer Conducted by the Society of Gynecologic Oncologists

Fulltext Access 5 Pages 2010

PRO: Patients With Metastatic/Recurrent Cervical Cancer Should Be Treated With Cisplatin Plus Paclitaxel

Fulltext Access 4 Pages 2010

PRO: Systemic Therapy for All Endometrial Cancers Should Be Paclitaxel Plus Carboplatin

Fulltext Access 4 Pages 2010

CON: Systemic Therapy for All Endometrial Carcinomas Should Not Be Paclitaxel Plus Carboplatin

Fulltext Access 4 Pages 2010

DNA Repair–Based Mechanisms of Platinum Resistance in Epithelial Ovarian Cancer: From Bench to Bedside

Fulltext Access 7 Pages 2010

Do Patients With Platinum-Resistant Epithelial Ovarian Cancer Benefit From Second-line Chemotherapy?

Fulltext Access 5 Pages 2010

Lysophosphatidic Acid in Patients With Ovarian Cancer

Fulltext Access 6 Pages 2010

Weekly Administration of Paclitaxel and Carboplatin in the Treatment of Advanced Ovarian or Peritoneal Cancers With Poor Performance Status

Fulltext Access 5 Pages 2010

The Clinical Impact of Computed Tomography Immediately Following Primary Chemotherapy in Patients With Epithelial Ovarian Cancer

Fulltext Access 4 Pages 2010